Veröffentlichungsdatum: 23 Februar 2010
Projektträger – zwischengeschaltetes Finanzinstitut
UCB S.A.
Ort
Beschreibung
Financing of UCB’s pharmaceutical research and development for the period 2010-2014.
Ziele
The project will contribute to private sector investments in R&D, mostly located in Europe, thus meeting the orientations that underpin the Lisbon’s Council decision and the Bank’s Knowledge Economy (i2i), research and development.
Kommentar(e)
The Risk Sharing Finance Facility (RSFF) is an innovative credit risk sharing scheme jointly set up by the European Commission and the European Investment Bank to improve access to debt financing for private companies or public institutions promoting activities with a higher financial risk profile in the fields of research, technological development, demonstration and innovation investments.
Sektor(en)
Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)
EUR 250 million.
Gesamtkosten (voraussichtlicher Betrag)
EUR 539 million.
Umweltaspekte
R&D activities included in the project will not materially change current R&D practice and will be carried out within existing facilities, making use of existing laboratories, pilot plants, clinical centres, etc. An EIA is therefore not required by EU Directive 97/11. Compliance of R&D activities with relevant EU legislation in particular in regards to animal testing will be also be verified during appraisal.
Auftragsvergabe
The promoter is a private company not operating in the Utilities sector, and is thus not covered by EU Directives on procurement. Procedures followed will be verified during appraisal.
Projektstatus
Unterzeichnet - 9/05/2012
Haftungsausschluss
Bis Finanzierungen vom Verwaltungsrat genehmigt und anschließend unterzeichnet werden, befinden sich die Projekte in der Prüfungs- oder Verhandlungsphase. Die Angaben auf dieser Seite sind daher unverbindlich.
Sie dienen lediglich der Transparenz und stellen nicht die offizielle EIB-Politik dar (vgl. auch die erklärenden Anmerkungen).